While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Victoza (liraglutide) is a prescription drug used to help manage type 2 diabetes and reduce the risk of certain diabetes-related heart problems. Victoza is given as a daily injection under the skin.

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

A new study presented at the American Academy of Orthopedic Surgeons meeting reveals the need to stop taking GLP-1 agonists ...

Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...

Victoza offers a second option in these cases, he added. Victoza is Novo Nordisk’s once-daily injectable GLP-1 agonist and made around $3.6 billion in sales last year, making it the top-selling ...

The medical director of the NHS has warned of the side effects of weight loss drugs after figures revealed the number of deaths associated with the jabs ...

FactCheck takes a look. Mounjaro, Ozempic, Rybelsus, Wegovy and Victoza are all drugs that can be used to aid with weight loss. Medical treatments, including jabs used for weight loss, are ...

The global anorexiant market is set for significant expansion, with a projected compound annual growth rate (CAGR) of 5.1% over the forecast period, according to a recent study by Future Market ...

Hikma launched liraglutide, a generic version of an earlier Novo Nordisk weight loss drug, in the US in December. Liraglutide, which Novo sells as Victoza for diabetes and Saxenda for weight loss, has ...

Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. Picture: Alamy Andy Morling, deputy head of enforcement at the Medicines and Healthcare ...